Stock Events

Stock Events

Lineage Cell Therapeutics (LCTX) Q2 2024 Earnings

9MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.04

-0.04

-0.03

-0.03

Details

Expected EPS

-0.038333

Actual EPS

-0.04

Surprise EPS

-0

Surprise Percent

+4.35%

Description

Lineage Cell Therapeutics (LCTX) has reported earnings of -0.04 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.